Reference
Goujard C, et al. Treating hypoparathyroidism with recombinant human parathyroid hormone (1-34): long-term safety concerns. Lancet 395: 1304, No. 10232, 18-24 Apr 2020. Available from: URL: http://doi.org/10.1016/S0140-6736%2820%2930538-9
Rights and permissions
About this article
Cite this article
Alfacalcidol/calcium carbonate/teriparatide. Reactions Weekly 1804, 18 (2020). https://doi.org/10.1007/s40278-020-78447-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-020-78447-2